Search results
Results from the WOW.Com Content Network
The Philippines is a low-HIV-prevalence country, with 0.1 percent of the adult population estimated to be HIV-positive, but the rate of increase in infections is one of the highest. [7] As of August 2019, the Department of Health (DOH) AIDS Registry in the Philippines reported 69,629 cumulative cases since 1984. [ 8 ]
An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals. It is thought that an HIV vaccine could either induce an immune response against HIV (active vaccination approach) or consist of ...
Japanese encephalitis virus: Japanese encephalitis: Available tests detecting JE virus-specific IgM antibodies in serum and/or cerebrospinal fluid, for example by IgM capture ELISA. Supportive Yes: unknown; evidence supports that it is infectious Kawasaki disease: Based on symptoms, ultrasound of the heart: Aspirin, immunoglobulin: No multiple ...
Flu vaccines used during the flu in 2009. This is a list of vaccine-related topics.. A vaccine is a biological preparation that improves immunity to a particular disease.A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins.
In 2008, 4.7 million people in Asia were living with human immunodeficiency virus (HIV). Asia's epidemic peaked in the mid-1990s, and annual HIV incidence has declined since then by more than half. Regionally, the epidemic has remained somewhat stable since 2000. [1] People living with HIV/AIDS , in absolute numbers for the year of 2008. Large ...
These include storage and transport of vaccines from the primary vaccine store down to the end-user at the health facility, and further down at the outreach sites. [21] Inappropriate storage, handling and transport of vaccines won't protect patients and may lead to needless vaccine wastage.
This page was last edited on 30 October 2020, at 07:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Various approaches for HIV vaccine development. As of 2020, no effective vaccine for HIV or AIDS is known. [61] A single trial of the vaccine RV 144 found a partial efficacy rate around 30% and has stimulated optimism in the research community regarding developing a truly effective vaccine. [62] Further trials of the vaccine are ongoing. [63] [64]